Results 21 to 30 of about 161,851 (302)

Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state [PDF]

open access: yes, 2017
Human respiratory syncytial virus (RSV) is the main cause of lower respiratory tract infections in young children. The RSV fusion protein (F) is highly conserved and is the only viral membrane protein that is essential for infection.
Chen, Man   +13 more
core   +2 more sources

RSV and non-RSV illness hospitalization in RSV immunoprophylaxis recipients: A systematic literature review

open access: yesJournal of Clinical Virology, 2020
Respiratory syncytial virus (RSV) immunoprophylaxis (IP) has been shown to reduce RSV hospitalization rates in high-risk infants; however, it is unclear whether RSV IP is associated with increased risk of non-RSV disease, particularly non-RSV hospitalizations.
Adam, Bloomfield   +3 more
openaire   +2 more sources

RSV Prevention in All Infants: Which Is the Most Preferable Strategy?

open access: yesFrontiers in Immunology, 2022
Respiratory syncytial virus (RSV) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalizations and a substantial number of outpatient visits, which result in a huge economic and healthcare burden.
S. Esposito   +6 more
semanticscholar   +1 more source

SARS-CoV-2 Vaccines: A Brief Review

open access: yesPediatric Respirology and Critical Care Medicine, 2020
SARS-CoV-2 has immensely changed the landscape in how vaccines are researched and developed. The timeline truncated for the propose of meeting the grave demand. Children stand to benefit from herd immunity for multiple reasons. Protection from SARS-CoV-2
Brandon Chatani, Daniel K. Ng
doaj   +1 more source

Molecular Detection of Upper Respiratory Tract Viral Infection with RSV, HPIV & Adenovirus among SARS-CoV2 Negative patients with respiratory illness admitted in tertiary care hospital in Eastern India

open access: yesArchives of Pharmaceutical Sciences Ain Shams University, 2023
Background: The most prevalent disease-causing agents in humans are respiratory viruses, which have a global influence on morbidity and death. The Adenovirus, respiratory syncytial virus (RSV), and parainfluenza viruses (HPIV) are the dominant ...
Nivedita Mukherjee   +4 more
doaj   +1 more source

Accurate PCR detection of influenza A/B and respiratory syncytial viruses by use of Cepheid Xpert Flu+RSV Xpress Assay in point-of-care settings: Comparison to Prodesse ProFlu+ [PDF]

open access: yes, 2018
The Xpert Flu+RSV Xpress Assay is a fast, automated in vitro diagnostic test for qualitative detection and differentiation of influenza A and B viruses and respiratory syncytial virus (RSV) performed on the Cepheid GeneXpert ...
Cohen, Daniel M   +12 more
core   +2 more sources

RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccines

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Respiratory syncytial virus (RSV) causes a substantial proportion of acute lower respiratory tract infections (LRTI) among infants. In low- and middle-income countries, RSV may be responsible for approximately 40% of all hospital admissions of infants ...
Rupali J. Limaye   +3 more
doaj   +1 more source

Oral administration of Clostridium butyricum rescues streptomycin-exacerbated respiratory syncytial virus-induced lung inflammation in mice

open access: yesVirulence, 2021
Changes in the intestinal microbiota indirectly impact the health of mucosa distal to the intestine, particularly the respiratory tract. However, the effects of intestinal microbiota dysbiosis on the regulation of respiratory syncytial virus (RSV ...
Wenwen Zhu   +6 more
doaj   +1 more source

Multicenter clinical evaluation of the Luminex Aries Flu A/B & RSV assay for pediatric and adult respiratory tract specimens [PDF]

open access: yes, 2017
Influenza A and B viruses and respiratory syncytial virus (RSV) are three common viruses implicated in seasonal respiratory tract infections and are a major cause of morbidity and mortality in adults and children worldwide. In recent years, an increasing
Buller, Richard S   +6 more
core   +2 more sources

Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.

open access: yesCochrane Database of Systematic Reviews, 2021
BACKGROUND Respiratory viruses are the leading cause of lower respiratory tract infection (LRTI) and hospitalisation in infants and young children. Respiratory syncytial virus (RSV) is the main infectious agent in this population.
L. Garegnani   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy